Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GRN1005 in NSCLC with Brain Metastases
NCT01497665Phase 2Terminated
- Sponsor
- Angiochem Inc.
- Start
- Nov 2011
- Primary completion
- Jan 2013
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Peptide-Drug Conjugates
- Countries
- 2
01
Overview
A Phase 2 trial of paclitaxel trevatide in non-small cell lung cancer (NSCLC), sponsored by Angiochem Inc.. Started Nov 2011; status: terminated.
02
Drugs
paclitaxel trevatide
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01497665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01497665.